Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine

Clinical Pharmacology and Therapeutics

Volumn 62, Issue 1, 1997, Pages 82-88

  Carrilho, Alexandre J F ^a   Medina, Wilson L ^a   Nakandakare, Edna R ^a   Quintão, Eder C R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; COLESTYRAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ANTICHOLESTEREMIC AGENTS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTYRAMINE; FEMALE; GLYCOPROTEINS; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE;

EID: 0030851316     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90154-5     Document Type: Article

References (32)

1. Quintão ECR. Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation? Atherosclerosis 1995;116:1-14.
2. Tall A. Plasma lipid transfer proteins. Annu Rev Biochem 1995;64:235-57.
3. Lagrost L. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1994;1215:209-36.
4. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991;88:2059-66.
5. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, et al. Increased high-density lipoprotein levels caused by a common cholesterylester transfer protein gene mutation. N Engl J Med 1990;323:1234-8.
6. Ohta T, Nakamura R, Takata K, Saito Y, Yamashita S, Horiuchi S, et al. Structural and functional differences of subspecies of apoA-1-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency. J Lipid Res 1995;36:696-704.
7. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester protein gene despite increases HDL levels. J Clin Invest 1996;97:2917-23.
8. Quinet EM, Agellon LB, Kroon PA, Marcel YL, Lee YC, Whitlock ME, et al. Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. J Clin Invest 1990;85:357-63.
9. Jiang XC, Agellon LB, Walsh A, Breslow JL, Tall AR. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. J Clin Invest 1992;90:1290-5.
10. Martin LJ, Connelly PW, Nancoo D, Wood N, Zhang ZJ, Maguire G, et al. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res 1993;34:437-46.
11. Jiang XC, Moulin P, Quinet E, Goldberg IJ, Yacoub LK, Agellon LB, et al. Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem 1991;266:4631-9.
12. McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne RW, et al. Plasma concentration of cholesteryl ester transfer protein in hyperlipoproteinemia: relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb 1991;11:797-804.
13. Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia. J Clin Invest 1991;87:1259-65.
14. Cheung MC, Austin MA, Moulin P, Wolf AC, Cryer D, Knopp RH. Effect of pravastatin on apolipoprotein-specific high density lipoprotein subpopulation and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia. Atherosclerosis 1993;102:107-19.
15. Ahnadi CE, Berthezène F, Ponsin G. Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects. Atherosclerosis 1993;99:219-28.
16. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
18. Havel RJ, Eder HA, Gragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34:1345-53.
19. Tatò F, Veja GL, Tall AR, Grundy SM. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipemia. Arterioscler Thromb Vase Biol 1995;15:112-20.
20. Albers JJ, Tollefson JH, Cheng CH, Steinmetz A. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis 1984;4:49-58.
21. Marcel YL, McPherson R, Hogue M, Czarnecka H, Zawadzki Z, Weech PK, et al. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipidemic subjects. J Clin Invest 1990; 85:10-7.
22. Quinet E, Tall AR, Ramakrishnan R, Rudel L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest 1991;87:1559-66.
23. Radeau T, Lau P, Robb M, McDonnell M, Ailhaud G, McPherson R. Cholesteryl ester transfer protein (CETP) mRNA abundance in human adipose tissue: relationship to cell size and membrane cholesterol content. J Lipid Res 1995;36:2552-61.
24. Einarsson K, Reihnér E, Björkhem I. On the saturation of the cholesterol 7-alpha-hydroxylase in human liver microsomes. J Lipid Res 1989;30:1477-81.
25. Reihnér E, Björkhem I, Angelin B, Ewerth S, Einarsson K. Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7-alpha-hydroxylase activity. Gastroenterology 1989;97:1498-505.
26. Stahlberg D, Reihnér E, Angelin B, Einarsson K. Interruption of the enterohepatic circulation of bile acids stimulates the esterification rate of cholesterol in human liver. J Lipid Res 1991;32:1409-15.
27. White LW. Feedback regulation of cholesterol biosynthesis: studies with cholestyramine. Circ Res 1972; 31:899-907.
28. Dory L, Bhattacharyya A, Strong J, Chappuis C. Hepatic low density lipoprotein receptors, HMG-CoA reductase, and plasma lipid and apolipoproteins in high- and low-responding rhesus monkeys: effect of cholestyramine treatment. J Lipid Res 1990;31:279-87.
29. Slater HR, Packard CJ, Bicker S, Shepherd J. Effects of cholestyramine on receptor-mediated plasma clearance and tissue uptake of human low density lipoproteins in the rabbit. J Biol Chem 1980;265:10210-3.
30. Kovanen P, Bilheimer DW, Goldstein JL, Jaramillo JJ, Brown M. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proc Natl Acad Sci USA 1981;78:1194-8.
31. Chao YS, Yamin TT, Alberts AW. Effects of cholestyramine on low density lipoprotein binding sites on liver membranes from rabbits with endogenous hypercholesterolemia induced by a wheat starchcasein diet. J Biol Chem 1982;257:3623-7.
32. Angelin B, Raviola CA, Innerarity TL, Mahley RW. Regulation of hepatic lipoprotein receptors in the dog. J Clin Invest 1983;71:816-31.